Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Peer Christiansen"'
Autor:
Stephen Hamilton-Dutoit, Maret L. Maliniak, Henrik Toft Sørensen, Kristina B. Christensen, Per Damkier, Peer Christiansen, Timothy L. Lash, Lindsay J Collin, Sinna Pilgaard Ulrichsen, Deirdre Cronin-Fenton, Rami Yacoub, Thomas P. Ahern
Publikováno v:
Collin, L J, Maliniak, M L, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Ulrichsen, S P, Damkier, P, Hamilton-Dutoit, S, Yacoub, R, Christiansen, P M, Sørensen, H T & Lash, T L 2021, ' Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study ', Breast cancer research : BCR, vol. 23, no. 1, pp. 103 . https://doi.org/10.1186/s13058-021-01480-1
Breast Cancer Research : BCR
Collin, L J, Maliniak, M L, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Ulrichsen, S P, Damkier, P, Hamilton-Dutoit, S, Yacoub, R, Christiansen, P M, Sørensen, H T & Lash, T L 2021, ' Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study ', Breast Cancer Research, vol. 23, no. 1, 103 . https://doi.org/10.1186/s13058-021-01480-1
Collin, L J, Maliniak, M L, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Ulrichsen, S P, Damkier, P, Hamilton-Dutoit, S, Yacoub, R, Christiansen, P M, Sørensen, H T & Lash, T L 2021, ' Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study ', Breast Cancer Research, vol. 23, 103 . https://doi.org/10.1186/s13058-021-01480-1
Breast Cancer Research, Vol 23, Iss 1, Pp 1-11 (2021)
Breast Cancer Research : BCR
Collin, L J, Maliniak, M L, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Ulrichsen, S P, Damkier, P, Hamilton-Dutoit, S, Yacoub, R, Christiansen, P M, Sørensen, H T & Lash, T L 2021, ' Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study ', Breast Cancer Research, vol. 23, no. 1, 103 . https://doi.org/10.1186/s13058-021-01480-1
Collin, L J, Maliniak, M L, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Ulrichsen, S P, Damkier, P, Hamilton-Dutoit, S, Yacoub, R, Christiansen, P M, Sørensen, H T & Lash, T L 2021, ' Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study ', Breast Cancer Research, vol. 23, 103 . https://doi.org/10.1186/s13058-021-01480-1
Breast Cancer Research, Vol 23, Iss 1, Pp 1-11 (2021)
Background Hypoxia-inducible factor-1α (HIF-1α) is a transcription factor that facilitates the adaptation of cancer cells to hypoxic conditions and may be prognostic of breast cancer recurrence. We evaluated the association of HIF-1α expression wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9e39bc949916f4137cca5c5dfff01a5
https://pure.au.dk/portal/da/publications/hypoxiainducible-factor1-expression-and-breast-cancer-recurrence-in-a-danish-populationbased-case-control-study(68e72280-51af-4af2-8ec1-638d84a3abdc).html
https://pure.au.dk/portal/da/publications/hypoxiainducible-factor1-expression-and-breast-cancer-recurrence-in-a-danish-populationbased-case-control-study(68e72280-51af-4af2-8ec1-638d84a3abdc).html
Autor:
Trine Tramm, Stephen Hamilton-Dutoit, James W. Baurley, Kristina Lystlund Lauridsen, Per Damkier, Anders Kjærsgaard, Peer Christiansen, Lindsay J Collin, Kristina B. Christensen, Maret L. Maliniak, Rebecca A. Silliman, Deirdre Cronin-Fenton, Timothy L. Lash, Michael E. Zwick, Thomas P. Ahern, Bent Ejlertsen, R. Benjamin Isett, Rebecca Nash, Henrik Toft Sørensen
Publikováno v:
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K, Silliman, R A, Toft Sørensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin-Fenton, D 2020, ' Metabolic Pathway Analysis and Effectiveness of Tamoxifen in Danish Breast Cancer Patients ', Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K B, Silliman, R A, Toft Sorensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin Fenton, D 2020, ' Metabolic pathway analysis and effectiveness of tamoxifen in Danish breast cancer patients ', Cancer Epidemiology, Biomarkers & Prevention, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Cancer Epidemiol Biomarkers Prev
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K B, Silliman, R A, Toft Sorensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin Fenton, D 2020, ' Metabolic pathway analysis and effectiveness of tamoxifen in Danish breast cancer patients ', Cancer Epidemiology, Biomarkers & Prevention, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Cancer Epidemiol Biomarkers Prev
Background: Tamoxifen and its metabolites compete with estrogen to occupy the estrogen receptor. The conventional dose of adjuvant tamoxifen overwhelms estrogen in this competition, reducing breast cancer recurrence risk by nearly half. Phase I metab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1801d69fb5cd7b94c2ec62c58bf25321
https://findresearcher.sdu.dk:8443/ws/files/162520147/1055_9965.EPI_19_0833.full.pdf
https://findresearcher.sdu.dk:8443/ws/files/162520147/1055_9965.EPI_19_0833.full.pdf
Autor:
Sinna Pilgaard Ulrichsen, Henrik Toft Sørensen, Lauren E. McCullough, Michael Goodman, Kristina B. Christensen, Kristina Lystlund Lauridsen, Per Damkier, Rami Yacoub, Lance A. Waller, Timothy L. Lash, Thomas P. Ahern, Bent Ejlertsen, Deirdre Cronin-Fenton, Peer Christiansen, Lindsay J Collin, Stephen Hamilton-Dutoit
Publikováno v:
Collin, L J, Ulrichsen, S P, Ahern, T P, Goodman, M, McCullough, L E, Waller, L A, Bang Christensen, K, Damkier, P, Hamilton-Dutoit, S, Lauridsen, K L, Yacoub, R, Christiansen, P M, Ejlertsen, B, Sørensen, H T, Cronin-Fenton, D P & Lash, T L 2020, ' 17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence : a Danish population-based study ', Acta Oncologica, vol. 59, no. 3, pp. 329-333 . https://doi.org/10.1080/0284186X.2019.1684560
Acta Oncol
Acta Oncol
BACKGROUND: Approximately 20–40% of patients diagnosed with breast cancer will experience a recurrence up to 20 years after their original diagnosis. 17?-hydroxysteroid dehydrogenase 1 and 2 (HSD17B1 and HSD17B2, respectively) regulate intratumoral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b1221ea8ab1bf3d1024c9bb6d4f0751
https://portal.findresearcher.sdu.dk/da/publications/2ac08303-0b6f-4061-acbe-e409048b9d9c
https://portal.findresearcher.sdu.dk/da/publications/2ac08303-0b6f-4061-acbe-e409048b9d9c
Publikováno v:
Zøylner, I A, Lomborg, K, Christiansen, P M & Kirkegaard, P 2019, ' Surgical breast cancer patient pathway : Experiences of patients and relatives and their unmet needs ' Health Expectations, vol. 22, no. 2, pp. 262-272 . https://doi.org/10.1111/hex.12869
Health Expectations : An International Journal of Public Participation in Health Care and Health Policy
Zøylner, I A, Lomborg, K, Christiansen, P M & Kirkegaard, P 2019, ' Surgical breast cancer patient pathway : Experiences of patients and relatives and their unmet needs ', Health Expectations, vol. 22, no. 2, pp. 262-272 . https://doi.org/10.1111/hex.12869
Health Expectations : An International Journal of Public Participation in Health Care and Health Policy
Zøylner, I A, Lomborg, K, Christiansen, P M & Kirkegaard, P 2019, ' Surgical breast cancer patient pathway : Experiences of patients and relatives and their unmet needs ', Health Expectations, vol. 22, no. 2, pp. 262-272 . https://doi.org/10.1111/hex.12869
BACKGROUND AND AIM: Breast cancer is the most common cancer disease in women worldwide. In Denmark, the law prescribes cancer patient pathways (CPPs) in general and thus also for breast cancer. Although results from patient satisfaction surveys show
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ce3059ce853c6e37c1cd9389c5af268
https://pure.au.dk/portal/da/publications/surgical-breast-cancer-patient-pathway(d353a060-a6cf-4891-ab29-e63cb0c22431).html
https://pure.au.dk/portal/da/publications/surgical-breast-cancer-patient-pathway(d353a060-a6cf-4891-ab29-e63cb0c22431).html
Autor:
Trine Tramm, Peer Christiansen, Anne Bodilsen, Hanne Melgaard Nielsen, Jonas Amstrup Funder, Anne Schmidt Sorensen, Marco Mele, Josephine Bruun
Publikováno v:
Mele, M, Sørensen, A S, Bruun, J, Funder, J A, Tramm, T, Bodilsen, A, Nielsen, H M & Christiansen, P M 2019, ' Inflammatory breast cancer : A review from our experience ', Breast Disease, vol. 38, no. 2, pp. 47-55 . https://doi.org/10.3233/BD-180365
INTRODUCTION: Inflammatory Breast Cancer (IBC) is a distinct and rare type of breast cancer accounting for up to 6% of all breast cancer cases in Europe. The aim of this study was to investigate diagnostic methods, treatments, and outcome after IBC i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c2fde238c6e05cc881054e1f438ab79
https://pure.au.dk/portal/da/publications/inflammatory-breast-cancer(c3af6599-1a4d-4e37-8e81-962726ba1a64).html
https://pure.au.dk/portal/da/publications/inflammatory-breast-cancer(c3af6599-1a4d-4e37-8e81-962726ba1a64).html
Autor:
Per Damkier, Thomas P. Ahern, Stephen Hamilton-Dutoit, Anders Kjærsgaard, Lindsay J Collin, Peer Christiansen, Kristina B. Christensen, Deirdre Cronin-Fenton, Kristina Lystlund Lauridsen, Timothy L. Lash, Henrik Toft Sørensen, Rami Yacoub
Publikováno v:
Collin, L J, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Damkier, P, Hamilton-Dutoit, S, Kjaersgaard, A, Lauridsen, K L, Yacoub, R, Christiansen, P, Sørensen, H T & Lash, T L 2019, ' Expression of survivin does not appear to influence breast cancer recurrence risk ', Acta Oncologica, vol. 58, no. 2, pp. 154-161 . https://doi.org/10.1080/0284186X.2018.1503419
BACKGROUND: Survivin is an inhibitor of apoptosis, and its expression associates with poor outcomes in multiple cancers. It may be a therapeutic target due to its unique expression in cancer cells.METHODS: We estimated the association between nuclear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11c5d4567c22bdcc224bb419fa7029e9
https://pure.au.dk/portal/da/publications/expression-of-survivin-does-not-appear-to-influence-breast-cancer-recurrence-risk(8edf1125-b428-4628-b8be-a770a766d5de).html
https://pure.au.dk/portal/da/publications/expression-of-survivin-does-not-appear-to-influence-breast-cancer-recurrence-risk(8edf1125-b428-4628-b8be-a770a766d5de).html
Autor:
Maj-Britt Jensen, Bo Grundtmann, Peer Christiansen, Anne Vibeke Lænkholm, Tove Filtenborg Tvedskov, Ann Knoop, Signe Korsgaard Skriver, Birgitte Bruun Rasmussen, Jürgen Handler, Bent Ejlertsen
Publikováno v:
Skriver, S K, Laenkholm, A-V, Rasmussen, B B, Handler, J, Grundtmann, B, Tvedskov, T F, Christiansen, P, Knoop, A S, Jensen, M-B & Ejlertsen, B 2018, ' Neoadjuvant letrozole for postmenopausal estrogen receptor-positive, HER2-negative breast cancer patients, a study from the Danish Breast Cancer Cooperative Group (DBCG) ', Acta Oncologica, vol. 57, pp. 1-7 . https://doi.org/10.1080/0284186X.2017.1401228
INTRODUCTION: Neoadjuvant endocrine treatment (NET) is a low-toxicity approach to achieve operability in locally advanced breast cancer, and to facilitate breast conservation in early breast cancer, particular in patients with highly estrogen recepto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04cf3ecf5be74027a71b12f95d3263aa
https://pure.au.dk/portal/da/publications/neoadjuvant-letrozole-for-postmenopausal-estrogen-receptorpositive-her2negative-breast-cancer-patients-a-study-from-the-danish-breast-cancer-cooperative-group-dbcg(00e87aba-9155-43c4-aa58-bd0b14890dc5).html
https://pure.au.dk/portal/da/publications/neoadjuvant-letrozole-for-postmenopausal-estrogen-receptorpositive-her2negative-breast-cancer-patients-a-study-from-the-danish-breast-cancer-cooperative-group-dbcg(00e87aba-9155-43c4-aa58-bd0b14890dc5).html
Autor:
Bent Ejlertsen, Thomas P. Ahern, Uffe Heide-Jørgensen, Peer Christiansen, Deirdre P. Cronin-Fenton, Timothy L. Lash, Henrik Toft Sørensen
Publikováno v:
Cronin-Fenton, D P, Heide-Jørgensen, U, Ahern, T P, Lash, T L, Christiansen, P, Ejlertsen, B & Sørensen, H T 2016, ' Low-dose aspirin, non-steroidal anti-inflammatory drugs, selective COX-2 inhibitors and breast cancer recurrence ', Epidemiology . https://doi.org/10.1097/EDE.0000000000000480
BACKGROUND: Aspirin, non-steroidal anti-inflammatory drugs (NSAIDs), and selective COX-2 inhibitors may improve outcomes in breast cancer patients. We investigated the association of aspirin, NSAIDs, and use of selective COX-2 inhibitors with breast
Publikováno v:
Jensen, M-B, Ejlertsen, B, Mouridsen, H T, Christiansen, P & Danish Breast Cancer Cooperative Group 2016, ' Improvements in breast cancer survival between 1995 and 2012 in Denmark : The importance of earlier diagnosis and adjuvant treatment ', Acta Oncologica, pp. 1-12 . https://doi.org/10.3109/0284186X.2015.1128119
Background Breast cancer mortality has declined from 1995 through 2012 which may be attributed to earlier diagnosis, changes in lifestyle risk factors, and improved treatments. To a large extent the relative contribution of these modalities are unkno
Autor:
Deirdre P. Cronin-Fenton, Anders Kjærsgaard, Peer Christiansen, Lindsay J Collin, Stephen Hamilton-Dutoit, Bent Ejlertsen, Timothy L. Lash, Henrik Toft Sørensen, Thomas P. Ahern, Per Damkier, Rebecca A. Silliman
Publikováno v:
Collin, L J, Cronin-Fenton, D P, Ahern, T P, Christiansen, P M, Damkier, P, Ejlertsen, B, Hamilton-Dutoit, S, Kjærsgaard, A, Silliman, R A, Sørensen, H T & Lash, T L 2018, ' Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark ', BMJ Open, vol. 8, no. 7, e021805, pp. e021805 . https://doi.org/10.1136/bmjopen-2018-021805
Collin, L J, Cronin-Fenton, D P, Ahern, T P, Christiansen, P M, Damkier, P, Ejlertsen, B, Hamilton-Dutoit, S, Kjærsgaard, A, Silliman, R A, Sørensen, H T & Lash, T L 2018, ' Cohort Profile : The Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark ', BMJ Open, vol. 8, no. 7, e021805 . https://doi.org/10.1136/bmjopen-2018-021805
BMJ Open
Collin, L J, Cronin-Fenton, D P, Ahern, T P, Christiansen, P M, Damkier, P, Ejlertsen, B, Hamilton-Dutoit, S, Kjærsgaard, A, Silliman, R A, Sørensen, H T & Lash, T L 2018, ' Cohort Profile : The Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark ', BMJ Open, vol. 8, no. 7, e021805 . https://doi.org/10.1136/bmjopen-2018-021805
BMJ Open
PurposeThe Predictors of Breast Cancer Recurrence (ProBe CaRe) study was established to evaluate modification of tamoxifen (TAM) effectiveness in premenopausal women through reduced activity of TAM-metabolising enzymes. It comprehensively evaluates t